KMTS צמיחה צפויה ברווח למניה לשנה הבאה kestramedical.com

The consensus net profit growth rate on the GURU.Markets chart reflects market expectations, where 15.90 determines the current value of the metric. The impeccable image of Kestra Medical Technologies (KMTS) is built on saving lives. Kestra Medical Technologies (KMTS) develops compact cardiac monitors for the rehabilitation of patients with heart pathologies. The unique format of wearable defibrillators allows the brand to exercise significant pricing power when charging insurance organizations.

This indicator reflects market consensus expectations for earnings per share (EPS) changes next year, allowing for an assessment of future business efficiency through the lens of fundamental value. By analyzing the vector of the consensus EPS forecast, an investor can weigh the growth potential of Kestra Medical Technologies (KMTS) against its ability to maintain pricing power for defibrillators amid the gradual expansion of market adoption.